ACM
MRTX
Asymmetry Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $6.44M | Buy |
43,876
+1,885
| +4% | +$277K | 3.42% | 15 |
|
|
2021
Q3 | $7.43M | Sell |
41,991
-15,988
| -28% | -$2.83M | 4.47% | 11 |
|
|
2021
Q2 | $9.37M | Buy |
57,979
+33,716
| +139% | +$5.45M | 6.44% | 5 |
|
|
2021
Q1 | $4.16M | Buy |
+24,263
| New | +$4.16M | 2.15% | 19 |
|
|
2020
Q1 | – | Sell |
-6,950
| Closed | -$896K | – | 38 |
|
|
2019
Q4 | $896K | Buy |
+6,950
| New | +$896K | 1.61% | 30 |
|